Guidance

Genomics and personalised medicines: partner with the UK to develop new treatments

Overview of UK research infrastructure for genomics technologies, and advantages of investment in the UK's life science sector to support new products.

• From: Life Sciences Organisation and Department for International Trade
• Published: 2 July 2019

Documents

Genomics and personalised medicine: partner with the UK to develop new treatments, diagnostics, and care solutions

HTML

Details

A summary of the UK’s strengths as a partner for genomics technologies and development of personalised medicines, including information on:

• research and development expertise
• clinical research infrastructure
• routes to product development
• regulatory approval

Published 2 July 2019